FDA Proposes Safety Study for Gardasil 9 Via Sentinel

Drug Industry Daily
A A
The FDA is proposing a surveillance plan for Merck’s Gardasil 9 to screen for four potential adverse risks associated with human papillomavirus vaccines.

To View This Article:

Login

Subscribe To Drug Industry Daily